ArticleFASEB bioAdvances2026
Altered Expression of Dual-Specificity Phosphatases in Macrophages Exposed to Lipid Nanoparticles.
Article in FASEB bioAdvances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute inflammation is rapidly elicited in response to pathogens, toxins, and other cellular components that interact with immune cells through surface receptors, activating signaling cascades that lead to the expression of molecules aimed at neutralizing the pathogen and stimulating other cells to begin the healing process. However, a robust inflammatory response can be detrimental if it is prolonged. Therefore, the inflammatory response must be tightly regulated to prevent secondary harmful effects. In this regard, cells contain molecular switches that turn the inflammatory process on and off. The rapid response to infection and injury is mediated by constitutive cellular proteins that are activated by posttranslational modifications, of which phosphorylation is the most common. Consequently, compensatory mechanisms often involve the removal of phosphate groups by phosphatases. A family of phosphatases known as dual-specificity phosphatases (DUSPs), which dephosphorylate both tyrosine and serine/threonine residues, has emerged as a critical mechanism for controlling inflammation. To date, more than 40 DUSPs have been identified in the human genome. Despite their shared catalytic specificity, they appear to participate in diverse cellular processes and are expressed in response to various stimuli. In the present study, we detected a distinctive pattern of DUSP expression in response to exogenous lipid nanoparticles and toxins. These observations suggest that the transcriptional regulation of several DUSPs may be coordinated. They also raise the possibility that DUSPs may play redundant roles to ensure the proper resolution of the inflammatory response.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.